Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus

December 2016

Basaglar (BAY-zuh-glar) will be a new insulin hitting pharmacy shelves.

You might hear it called a "generic" for Lantus...but it's NOT.

Basaglar is similar to Lantus. Both contain 100 units/mL of long-acting insulin glargine...are usually dosed once daily...and the pens deliver up to 80 units per injection.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Work Closely With Nurses to Avoid Problems Due to Missing Doses
Med Safety Put Strategies in Place to Prevent Errors With Neuromuscular Blockers
Infection Control Look for Isolation Precaution Signs Before Entering Patient Rooms
Acute Pain Document All the Details of Opioid Regimens on Med Histories
Heart Failure Make Diuretics Available ASAP to Reduce Acute Heart Failure Symptoms
Blood Products Don't Automatically Substitute Different Brands of IVIG
Medication Errors Watch for Meds That Are Prone to 10-Fold Dosing Errors
Adverse Events Document Allergic Reactions to Excipients on Med Histories
Insulin Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus
Gout Expect More Corticosteroid Orders for Gout Attacks
Supplements Expect Patients to Try Turmeric Supplements for Arthritis

Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus

Practical advice for a better career, with unlimited access to CE

Table of Contents